-
Panacea Biotec supplies second component of Sputnik V vaccine in India
September 7, 2021Panacea Biotec has supplied the first shipment of the second component of the Russian Sputnik V...
-
Kerala HC directs Centre to allow Covishield 2nd dose after four weeks
September 6, 2021With continued surge in covid cases in Kerala, the state High Court on Monday directed the...
-
Hetero gets DCGI nod for using Tocilizumab biosimilar in COVID treatment
September 6, 2021Drug firm Hetero on Monday said it has received emergency use authorisation from Drug Controller General...
-
US drug regulator USFDA approves Zydus Cadila’s diabetes medication drug
September 6, 2021Drug firm Zydus Cadila on Monday said it has received approval from the US health regulator...
-
Lupin, TB Alliance team up for treatment of drug-resistant Tuberculosis
September 6, 2021Drugmaker Lupin on Monday said non-profit drug developer TB Alliance has granted it a non-exclusive licence...
-
India for early outcome of TRIPS waiver for COVID vax, diagnostics
September 4, 2021India has pitched for an early outcome of the TRIPS waiver proposal for COVID-19 vaccines, therapeutics...
-
Coronavirus continues to rage across the world, new variant C.1.2 reported in South Africa
September 1, 2021As the coronavirus continues to rage across the world, a new variant, yet again, has been...
-
Increase in COVID-19 vaccine production in India raises export hopes
August 30, 2021With boost in COVID-19 vaccine manufacturing in India following the setup of new production lines, the...
-
Reliance Life Sciences gets nod for clinical trials of protein-based COVID-19 vaccine
August 27, 2021Reliance Life Sciences received green light from the drug regulatory authority on Thursday to conduct clinical...
-
Majority of Indians experience no or mild side effects post 2 doses of Covid vax: Survey
August 25, 2021Majority of Indians experienced no or only mild side effects after taking two doses of COVID-19...
